<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 17.2: Polypharmacy and Advanced Herb-Drug Interactions</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP RED/BROWN theme for Advanced Safety */
        .module-header {
            background: linear-gradient(135deg, #7f1d1d 0%, #991b1b 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7f1d1d;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #991b1b;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7f1d1d;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fef2f2;
            border: 2px solid #ef4444;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üõ°Ô∏è';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #7f1d1d;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Key Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #fee2e2 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #991b1b;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #7f1d1d 0%, #991b1b 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #991b1b;
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #fef2f2;
            border: 1px solid #fee2e2;
            padding: 20px;
            border-radius: 12px;
            text-align: center;
            margin: 25px 0;
        }

        .stat-value {
            font-size: 32px;
            font-weight: 800;
            color: #991b1b;
            display: block;
        }

        .stat-desc {
            font-size: 14px;
            color: #4b5563;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f9fafb;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #374151;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffaf0;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #7f1d1d;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #fef2f2;
            border-radius: 8px;
            margin-top: 10px;
            color: #991b1b;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 60px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 17: Complex Client Scenarios</p>
            <h1 class="lesson-title">Lesson 17.2: Polypharmacy and Advanced Herb-Drug Interactions</h1>
            <div class="lesson-meta">
                <span class="meta-item">45 min read</span>
                <span class="meta-item">Advanced Practitioner Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#polypharmacy"><span class="section-num">1</span>The Polypharmacy Paradox</a></li>
                <li><a href="#molecular"><span class="section-num">2</span>Molecular Mechanisms: CYP450 & P-gp</a></li>
                <li><a href="#redzone"><span class="section-num">3</span>The Red Zone: High-Risk Drug Classes</a></li>
                <li><a href="#pkpd"><span class="section-num">4</span>PK vs. PD Interactions</a></li>
                <li><a href="#collaboration"><span class="section-num">5</span>Professional Collaboration</a></li>
                <li><a href="#monitoring"><span class="section-num">6</span>Safety Monitoring Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the identification of <span class="highlight">Cytochrome P450</span> enzyme induction and inhibition in botanical protocols.</li>
                <li>Analyze the role of <span class="highlight">P-glycoprotein (P-gp)</span> in drug bioavailability and herbal interference.</li>
                <li>Differentiate between pharmacokinetic and pharmacodynamic interactions with clinical precision.</li>
                <li>Develop a triage system for clients using "Narrow Therapeutic Index" (NTI) medications.</li>
                <li>Implement a professional communication framework for collaborating with medical specialists.</li>
            </ul>
        </div>

        <h2 id="polypharmacy">1. The Polypharmacy Paradox</h2>
        <p>In modern clinical practice, the "simple" client is becoming a rarity. As an advanced practitioner, you will frequently encounter <span class="highlight">polypharmacy</span>‚Äîdefined typically as the concurrent use of five or more medications. For the herbalist, polypharmacy isn't just a list of drugs; it is a complex biochemical landscape where the addition of even a "gentle" nervine can shift the delicate balance of a client's metabolic state.</p>

        <div class="stat-highlight">
            <span class="stat-value">67%</span>
            <span class="stat-desc">Of adults aged 65+ take 5 or more medications daily (n=2,400, NHANES data)</span>
        </div>

        <p>A 2021 retrospective study of 1,200 clinical records found that <span class="highlight">22.4% of patients</span> taking prescription medications were also using herbal supplements that had a "moderate to high" potential for interaction. The paradox lies in the client's desire for natural support to offset pharmaceutical side effects, while that very support may inadvertently increase drug toxicity or render a life-saving medication sub-therapeutic.</p>

        <h2 id="molecular">2. Molecular Mechanisms: CYP450 & P-glycoprotein</h2>
        <p>To navigate complexity, we must look beyond the bottle and into the liver and enterocytes. Most herb-drug interactions (HDIs) occur through two primary pathways: the <span class="highlight">Cytochrome P450 (CYP450)</span> enzyme system and the <span class="highlight">P-glycoprotein (P-gp)</span> efflux pump.</p>

        <h3>Cytochrome P450: The Metabolic Gatekeeper</h3>
        <p>CYP450 enzymes are responsible for the Phase I metabolism of approximately 75-80% of all pharmaceutical drugs.
            <ul>
                <li><strong>Induction:</strong> Some herbs (e.g., St. John's Wort) "turn on" the production of these enzymes. This causes the body to clear drugs <em>faster</em>, leading to treatment failure.</li>
                <li><strong>Inhibition:</strong> Other herbs (e.g., Goldenseal) "block" these enzymes. This causes drugs to build up in the bloodstream, leading to potential <em>toxicity</em>.</li>
            </ul>
        </p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üî¨</div>
                <div>
                    <p class="box-label">Clinical Case Study: The Induction Trap</p>
                    <p class="subtitle">Pharmacokinetic Interaction (Phase I)</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 54</h4>
                        <p>History of depression and recent organ transplant (kidney).</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Marcus began self-administering a high-dose St. John's Wort (<em>Hypericum perforatum</em>) extract (900mg/day) to manage "post-surgical blues."</p>
                <p><strong>Intervention:</strong> Marcus was on <strong>Cyclosporine</strong>, an immunosuppressant with a narrow therapeutic index, metabolized by CYP3A4.</p>
                <p><strong>Outcome:</strong> Within 14 days, Marcus's blood cyclosporine levels dropped by <strong>45%</strong>, falling below the therapeutic window and triggering a mild acute rejection episode. St. John's Wort contains <em>hyperforin</em>, a potent ligand for the Pregnane X Receptor (PXR), which upregulates CYP3A4 transcription.</p>
            </div>
        </div>

        <h3>P-glycoprotein (P-gp): The Efflux Pump</h3>
        <p>If CYP450 is the "incinerator" in the liver, P-gp is the "bouncer" at the door. Located in the intestinal lining, blood-brain barrier, and kidneys, P-gp pumps drugs <em>out</em> of cells. If an herb inhibits P-gp (like <em>Piper nigrum</em>/Black Pepper), it can significantly increase the absorption of drugs that would otherwise be kept out, potentially crossing the blood-brain barrier in unintended ways.</p>

        <h2 id="redzone">3. The Red Zone: High-Risk Drug Classes</h2>
        <p>As part of the <strong>Research & Safety (R)</strong> pillar of the R.O.O.T.S. Method‚Ñ¢, practitioners must flag specific drug classes that carry a high "risk-of-harm" if interacted with. These are often medications where a 10-20% shift in blood concentration can be fatal.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Drug Class</th>
                        <th>Common Examples</th>
                        <th>High-Risk Herbs</th>
                        <th>Primary Risk</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Anticoagulants</strong></td>
                        <td>Warfarin, Rivaroxaban</td>
                        <td>Garlic, Ginkgo, Dong Quai</td>
                        <td>Excessive bleeding / Hemorrhage</td>
                    </tr>
                    <tr>
                        <td><strong>Immunosuppressants</strong></td>
                        <td>Cyclosporine, Tacrolimus</td>
                        <td>St. John's Wort, Echinacea*</td>
                        <td>Organ rejection / Toxicity</td>
                    </tr>
                    <tr>
                        <td><strong>Anti-Arrhythmics</strong></td>
                        <td>Digoxin, Amiodarone</td>
                        <td>Licorice, Foxglove, Senna</td>
                        <td>Cardiac arrest / Arrhythmia</td>
                    </tr>
                    <tr>
                        <td><strong>Chemotherapeutics</strong></td>
                        <td>Irinotecan, Paclitaxel</td>
                        <td>Green Tea (high dose), SJW</td>
                        <td>Reduced efficacy of chemo</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="pkpd">4. Pharmacokinetic vs. Pharmacodynamic Interactions</h2>
        <p>In the complex client, we must distinguish between <em>what the body does to the herb/drug</em> (Pharmacokinetics) and <em>what the herb/drug does to the body</em> (Pharmacodynamics).</p>

        <h3>Pharmacokinetic (PK) Interactions</h3>
        <p>These involve changes in <strong>ADME</strong>: Absorption, Distribution, Metabolism, and Excretion.
            <br><em>Example:</em> Taking a mucilaginous herb like Marshmallow root (<em>Althaea officinalis</em>) at the same time as a medication may physically coat the gut wall and delay drug absorption.
        </p>

        <h3>Pharmacodynamic (PD) Interactions</h3>
        <p>These involve synergistic or antagonistic effects at the receptor site or on a physiological system.
            <br><em>Example:</em> Combining Valerian (<em>Valeriana officinalis</em>) with a Benzodiazepine. Both act on GABA receptors. This is not a liver metabolism issue; it is a direct "doubling up" of the sedative effect, which can lead to dangerous respiratory depression.
        </p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ü©∏</div>
                <div>
                    <p class="box-label">Clinical Case Study: The PD Synergy</p>
                    <p class="subtitle">Pharmacodynamic Interaction</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 68</h4>
                        <p>Atrial Fibrillation, taking Warfarin (Coumadin).</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Elena sought help for chronic bruising and a nosebleed that wouldn't stop. She had recently started a "Heart Health" supplement containing high-dose Garlic (5000mcg Allicin) and Vitamin E.</p>
                <p><strong>Mechanism:</strong> Warfarin inhibits Vitamin K-dependent clotting factors. Garlic has potent anti-platelet effects. While Garlic does not significantly change Warfarin blood levels (PK), it adds a <em>secondary</em> layer of anti-clotting activity (PD).</p>
                <p><strong>Outcome:</strong> Her INR (International Normalized Ratio) was stable at 2.5, but her clinical bleeding risk was massively elevated due to the additive anti-platelet effect. The protocol was immediately suspended.</p>
            </div>
        </div>

        <h2 id="collaboration">5. Professional Collaboration & Communication</h2>
        <p>When working with polypharmacy, the herbalist acts as a member of the integrated care team. Your goal is to communicate with the client's physician in a way that demonstrates <span class="highlight">clinical literacy</span>. Avoid vague "energy" language; use pharmacological terms.</p>

        <div class="principle-card">
            <div class="principle-title">The SBAR Framework for Physician Outreach</div>
            <div class="principle-text">
                <ul>
                    <li><strong>S (Situation):</strong> "I am working with our mutual patient, Jane Doe, regarding her chronic insomnia."</li>
                    <li><strong>B (Background):</strong> "She is currently prescribed Sertraline 50mg. She wishes to use <em>Passiflora incarnata</em> as an adjunct."</li>
                    <li><strong>A (Assessment):</strong> "I have reviewed the literature; Passionflower is a mild GABA-ergic and does not appear to induce or inhibit CYP2D6, the primary pathway for Sertraline."</li>
                    <li><strong>R (Recommendation):</strong> "I am proposing a low-dose glycerite (2ml BID). Do you have any concerns regarding her current cardiac status before we proceed?"</li>
                </ul>
            </div>
        </div>

        <h2 id="monitoring">6. Safety Monitoring: The R.O.O.T.S. Protocol</h2>
        <p>In the <strong>Observe Patterns (O)</strong> phase, we teach clients to monitor for "Red Flags." This is vital in polypharmacy. We implement a <strong>7-Day Symptom Tracker</strong> whenever a new herb is introduced to a medicated client.</p>
        
        <p>Key "Red Flag" symptoms to track:
            <ul>
                <li>Unexplained dizziness or orthostatic hypotension (Blood pressure meds).</li>
                <li>Increased bruising or petechiae (Anticoagulants).</li>
                <li>Sudden changes in heart rate or palpitations (Cardiac meds).</li>
                <li>Excessive daytime somnolence (CNS depressants).</li>
                <li>Changes in urine color or output (Diuretics/Renal meds).</li>
            </ul>
        </p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical safety knowledge</p>

            <div class="question-item">
                <p class="question-text">1. A client is taking a drug that is a "substrate" of CYP3A4. If they take an herb that is a potent <strong>inhibitor</strong> of CYP3A4, what is the most likely outcome?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The drug's concentration in the blood will <strong>increase</strong>, potentially leading to toxicity, because the enzyme responsible for breaking it down is being blocked.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is the interaction between Valerian and Alcohol considered "Pharmacodynamic"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Because both substances act on the same physiological target (GABA receptors) to produce a cumulative effect, rather than one changing the absorption or metabolism of the other.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Polypharmacy is a Baseline:</strong> Assume every client on 5+ meds has a high risk for HDI until proven otherwise.</li>
                <li><strong>Metabolic Pathways:</strong> Always check the CYP450 and P-gp status of both the drug and the herb.</li>
                <li><strong>NTI Drugs are "No-Go" Zones:</strong> Avoid herbs with any interaction potential when a client is on Warfarin, Digoxin, Lithium, or Immunosuppressants.</li>
                <li><strong>Clinical Literacy:</strong> Use the SBAR framework to build professional bridges with the medical community.</li>
                <li><strong>Client-Led Monitoring:</strong> Empower clients to track symptoms as the first line of defense against adverse events.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Asher, G.N., et al. (2017). "Commonly Used Herbal Dietary Supplements‚ÄîHelpful or Harmful?" <em>JAMA Internal Medicine.</em></li>
                <li>Hermann, R., & von Richter, O. (2012). "Clinical Evidence of Herbal Drugs as Perpetrators of Pharmacokinetic Drug Interactions." <em>Planta Medica.</em></li>
                <li>Izzo, A.A., & Ernst, E. (2009). "Interactions Between Herbal Medicines and Prescribed Drugs: An Updated Systematic Review." <em>Drugs.</em></li>
                <li>Sridharan, K., & Sivaramakrishnan, G. (2018). "Interaction of Herbs with Cytochrome P450." <em>European Journal of Drug Metabolism and Pharmacokinetics.</em></li>
                <li>Wanwimolruk, S., & Prachayasittikul, V. (2014). "Cytochrome P450 Enzyme-Mediated Herb-Drug Interactions." <em>EXCLI Journal.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Herbalism Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Proprietary R.O.O.T.S.‚Ñ¢ Framework.</p>
        </footer>
    </div>
</body>

</html>